Hiroki Koda

700 citations
39 papers · 484 indexed · h-index 11
Topics
Pancreatic and Hepatic Oncology Research (25 papers)Gallbladder and Bile Duct Disorders (25 papers)Pediatric Hepatobiliary Diseases and Treatments (10 papers)
Partner nations
JapanEgyptUnited States

In The Last Decade

Hiroki Koda

31 papers receiving 468 citations

Peers

Hiroki Koda
Comparison fields: 5 of 51
  • Oncology 355
  • Surgery 220
  • Pulmonary and Respiratory Medicine 213
  • Radiology, Nuclear Medicine and Imaging 114
  • Artificial Intelligence 81
Replace Qiu-Cheng Wang with:
Qiu-Cheng Wang China
Takahide Shinagawa Japan
Nozomi Okuno Japan
Maria Ciolina Italy
Zixuan Cheng China
Jun Ki Min South Korea
Hidehito Arimitsu Japan
Yantao Tian China
Hiroki Koda relative to Qiu-Cheng Wang China Qiu-Cheng Wang's profile →
Citations per field
00.5×1.5×1.9×
Qiu-Cheng Wang · 1×
Citations per year

Countries citing papers authored by Hiroki Koda

Since Specialization
Citations

This map shows the geographic impact of Hiroki Koda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Koda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Koda more than expected).

Fields of papers citing papers by Hiroki Koda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Koda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Koda. The network helps show where Hiroki Koda may publish in the future.

Co-authorship network of co-authors of Hiroki Koda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Koda. A scholar is included among the top collaborators of Hiroki Koda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Koda. Hiroki Koda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 0
6 0
7 3
8 1
9 0
10 1
11 9
12 3
13 19
14 64
15 7
16 21
17 17
18 8
19 13
20 2

About Hiroki Koda

Hiroki Koda is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 39 papers that have together received 484 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (25 papers), Gallbladder and Bile Duct Disorders (25 papers) and Pediatric Hepatobiliary Diseases and Treatments (10 papers). The work is most often cited by research in Oncology (355 citations), Health Informatics (11 citations) and Pulmonary and Respiratory Medicine (213 citations). Hiroki Koda has collaborated with scholars based in Japan, Egypt and United States. Frequent co-authors include Kazuo Hara, Nobumasa Mizuno, Nozomi Okuno, Takamichi Kuwahara, Yasumasa Niwa, Shimpei Matsumoto, Yusuke Kurita, Masahiro Obata, Hajime Isomoto and Masahiro Tajika. Their work appears in journals such as Gastroenterology, Scientific Reports and World Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026